Key result
Ibuprofen is evaluated for the prevention of patent ductus arteriosus in preterm and low birth weight infants, though specific efficacy outcomes are not detailed in the abstract.
Population
Preterm and/or low birth weight infants
Design
Systematic review
Authors
Loading...
Prophylactic ibuprofen should not be used in preterm infants; confirms no net short-term benefit despite reduced PDA and surgery.
Key points are not available for this paper at this time.
Ohlsson et al. (2020) studied this question. Ibuprofen is evaluated for the prevention of patent ductus arteriosus in preterm and low birth weight infants, though specific efficacy outcomes are not detailed in the abstract.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: